LDP Pharma Study Group Calls for Expanding Sakigake Premium, Creating New Premium

November 15, 2023
A study group under the ruling Liberal Democratic Party (LDP) on November 14 broadly approved a proposal towards the FY2024 reimbursement and tax policy reform, calling for enhancing rewards in the price-setting of innovative medicines being quickly brought to Japan...read more